French President Emmanuel Macron has urged European companies to pause their investments in the U.S. following President Trump's controversial global tariffs. This call comes as the EU considers a powerful response to protect its trade interests.
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
Amazon MGM is officially moving forward with a new James Bond film, with renowned producers Amy Pascal and David Heyman at the helm. After gaining creative control, the next chapter of the iconic franchise is set to thrill audiences worldwide!
Amazon MGM Studios concluded CinemaCon with a remarkable group selfie featuring Hollywood stars. Executives emphasized their commitment to delivering 15 films a year by 2027, showcasing a bold slate designed for theaters.
A new ESA documentary reveals the alarming truth about space debris, with 70% of launched satellites still in orbit. Could our reliance on satellite technology lead to a catastrophic crisis in space?
U.S. stocks dropped after President Trump announced new tariffs of at least 10%, raising fears of a global trade war. Major companies like Nike and GM saw significant losses, with traders reacting to unexpected tariff rates.
Meta is set to revolutionize the smart glasses market with its upcoming Hypernova model, featuring advanced graphics, gesture tracking, and more. Priced between $1,000 and $1,400, these glasses promise to enhance your daily life like never before!
Car sales in the U.S. surged by 13.6% in March, with electric vehicles leading the charge. Automakers like GM and Ford reported significant gains, but looming tariffs could impact future sales.
Meta is set to launch its high-end Ray-Ban smart glasses, codenamed Hypernova, featuring a built-in screen and advanced camera. Priced between $1,000 and $1,400, these glasses redefine wearable tech with gesture controls and app capabilities!
As President Trump prepares to unveil a major tariff plan, pharmaceutical companies are lobbying for a gradual implementation to mitigate the impact on drug prices and supply. With potential tariffs looming, how will the industry adapt?
